NASD · Healthcare · Medical Devices · USA
Bruker Corp is a mid cap company (market value between $2 billion and $10 billion) in the Medical Devices industry.
Bruker Corp develops, manufactures, and distributes high-performance scientific instruments and analytical solutions for life and materials science research. The company operates four segments offering magnetic resonance, mass spectrometry, chromatography, X-ray, microscopy, and spectroscopy technologies serving academic institutions, pharmaceutical and biotechnology companies, and clinical laboratories worldwide.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Bruker Corp stock.
Overvalued: intrinsic value $17.02 per share, market price $61.36, margin of safety -260.4% (as of 2026-11-17).
Discounting its cash flows at 9.9% (average of 2 methods) values the shares at $17.02; the price of $61.36 is 260% above that value, and 74% of that value comes from beyond year five.
17 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
45 more in this industry show a wider margin of safety.
BRKR is overvalued (as of the 2026-11-17 close). Discounting its cash flows at 9.9% (average of 2 methods) values the shares at $17.02; the price of $61.36 is 260% above that value, and 74% of that value comes from beyond year five.
$17.02 per share (as of the 2026-11-17 close), against a market price of $61.36. That is a margin of safety of -260.4%. The value is the average of the 2 valuation methods that apply to this company, recomputed every night after the US close.